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ABSTRACT

Growth cones direct axon pathfinding during neural development by detecting
environmental stimuli, known as axon guidance molecules. In vitro studies have shown
inhibitory axon guidance molecules to cause growth cones to change morphology to what
is called a collapsed growth cone. Lysophosphatidic acid (LPA) has been demonstrated to
collapse growth cones in culture, and thus it may act as an inhibitory molecule. However,
identification of what LPA receptor is responsible for this physiological response is
unknown. To investigate which receptor elicits collapse, we focused on LPA receptor-4
(LPA4) by designing a CRISPR construct to mutate Lpar4 in chick retinal ganglion cells
(RGCs). Through retinal injections, we will introduce our CRISPR construct and isolate
mutated retinal tissue to observe whether mutating Lpar4 abolishes RGC growth cone
collapse. Preliminary data suggests our injection delivery system can successfully target
RGCs. Moreover, we have successfully cloned five guide RNAs (gRNA) and obtained
sequence results from gRNAs1-3 that show gRNA 1 and 2 have a high mutation rate in a
DF1-Cas9 cell line.
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Chapter 1

1.1

INTRODUCTION

Glaucoma, Central Nervous System Injury
Research estimates that over 3 million Americans will suffer from glaucoma by

2020 and it is estimated that a large population of individuals have glaucoma but have not
received a diagnosis (Friedman et al., 2004). Individuals who suffer from glaucoma, optic
nerve damage, or injury to the central nervous system (CNS, brain and spinal cord) will
have permanent nerve damage. The major issue is nerves in the CNS do not regenerate
once damage has occurred. One prominent model for nerve regeneration is the visual
system since these neurons travel long distances towards their target during embryonic
development. As a result, this makes understanding development of visual neurons by
how they pathfind and organize an essential model for uncovering molecular cues that
could potentially be induced/reduced after CNS damage to facilitate nerve regeneration.
How neural circuits are established during development and how specific neural
connections are made with their synaptic partner remains an intriguing and pivotal
question in neurobiology.
Unfortunately, there are no current therapeutic treatments to help aid nerve
regeneration. Therefore, research has investigated why the CNS lacks regeneration
completely. One significant reason is that many inhibitory factors exist within our CNS
physiology (e.g., Semaphorins, Lysophospholipids, glial scarring, or extracellular matrix
molecules) (Pfeiffenberger et al., 2006; Schwab and Theornen, 1985; Schwab and
Caroni, 1988). The inability for CNS nerves to regenerate is why biomedical research
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must understand the underlying factors within our physiology which prevents
regeneration.
The issue of why regeneration in the CNS is completely absent has been an
ongoing investigation since the early 1900s. Early in vitro studies with dissociated
sensory or sympathetic neurons cultured using adult rat sciatic (peripheral nervous
system—PNS) or optic (CNS) nerves revealed differences in regenerative properties
between PNS and CNS nerves. In fact, axons were found in abundance among sciatic
nerve tissue, whereas neurite outgrowth among optic nerve tissue was absent (Schwab
and Thoenen, 1985). Soon afterwards, Schwab and Caroni (1988) would discover that
nonpermissive substrates are expressed after developmental periods within the CNS,
thereby inhibiting future neurite outgrowth. This nonpermissive substrate included
myelin produced by oligodendrocytes (CNS) to surround axons in order to enhance
propagation of action potentials between neurons. Within the PNS, Schwann cells handle
myelin production and do not restrict neurite outgrowth in vitro (Schwab and Caroni,
1988). The unique differences between the nervous system demonstrates that there are
many more biological factors that need to be investigated to provide us with a better
understanding of how neuronal cells communicate within their environment.

1.2

Axon pathfinding during development
During neural circuit formation, axons must navigate through various tissues,

which means being able to respond to a changing environment. Axons of neurons
navigate during pathfinding, find specific target areas, identify target neurons, and
establish functioning synapses with appropriate synaptic targets. A prominent model for
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nerve growth is the visual system since it is well-established that visual neurons organize
in a highly specific topographic map (for review, see Erskine and Herrera, 2007). Retinal
ganglion cells (RGCs) in the eye grow and project their axons towards their synaptic
targets in the brain (Schmitt et al., 2006; for review, see Erskine and Herrera, 2007). The
highly reproducible pattern of axons navigating along distinct trajectories suggests that
axons are guided by cues along their journey (Tessier-Lavigne and Goodman, 1996). A
well-established model for RGC development is chick; additionally, it is easily accessible
during development. Chick RGC axons grow contralateral from the retina to synaptic
targets in the tectum of the brain, the visual processing region in chicken. This precision
is made possible by guidance cues to ensure neurons synapse at the correct target region
(optic tectum in chicken and zebrafish or lateral geniculate nucleus and superior
colliculus in mammals) followed by pruning to reorganize in the specific patterning of
visual neurons (Sperry, 1963). As such, investigating how neurons within the visual
system reach their synaptic target is an essential developmental model to uncover
molecular cues that govern axon pathfinding that could be therapeutically
induced/reduced after CNS damage to facilitate nerve regeneration.
These RGC axons must travel long-distances through various tissues and interact
with cues in the cellular environment, which is possible by a specialized structure at the
leading edge of a developing axon known as a growth cone. A growth cone is a motile
structure that is equipped with distinct receptors that provide communication with the
extracellular environment to pioneer an axon (Tessier-Lavigne and Goodman, 1996). At
the proximal part of the growth cone, this actin network is associated with microtubules.
Growth cone motility is induced through the activation of cell surface receptors that
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signal through complex pathways such as Rho and ROCK, which will ultimately control
the assembly or disassembly of actin filaments (Huber et al., 2003). A growth cones must
rapidly respond to its changing environment. A repertoire of guidance receptors is rapidly
responding to the changing environment, thus allowing a growth cone to navigate
towards its final target (Tessier-Lavigne and Goodman, 1996). The cues that a growth
cone interacts with are known as axon guidance molecules. These axon guidance
molecules are signaling molecules that activate receptors expressed on growth cones to
guide the growing axons (Schmitt et al., 2006; for review, see Erskine and Herrera,
2007). A growth cone’s dynamic behavior is responsive to multiple sources of
information to ensure an axon reaches its target with an impressive level of accuracy.
Additionally, the formation of neural networks means that precise navigation and
connections are made with appropriate targets. The chemotactic cues allow for growth of
axons over long distances which influences an array of signaling pathways, thus
facilitating cytoskeletal and membrane remodeling of a growth cone.
There has been significant work around axon guidance molecules within the
visual system. These axon guidance molecules are characterized as either attractive or
repulsive (for review, see Herrera et al., 2019). Guidance cues determine the route by a
combination of attractive and repulsive cues that can be either localized and act at shortrange, or act over long distances (Tessier-Lavigne and Goodman, 1996; Dickson, 2002).
For nearly 30 years, a spectrum of guidance cues has been identified. These are the major
families, but there are other molecules too: semaphorins, ephrins, netrins, and slits (for
review, see Reynes and Cook, 1995; Stoeckli, 2017; Stoeckli, 2018). Besides the
expansion of guidance cues, the overall complexity of axon pathfinding is expanding,
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such as our understanding that guidance cues can mediate more than one cellular
response. Recent work suggests that a novel set of molecules, Lysophospholipids, may be
axon guidance cues (Birgbauer and Chun, 2010; Fincher et al., 2014; Birgbauer, 2015).

1.3

Lysophosphatidic Acid (LPA)
Lysophospholipids are an important family of signaling molecules, and a

prominent member is lysophosphatidic acid (LPA); it is a simple phospholipid composed
of a phosphate, a glycerol, and a fatty acid. LPA is present in all eukaryotic tissues at low
concentrations, and at higher concentrations (sub-micromolar range) in blood plasma.
The signaling effects by LPA are mediated by G protein-coupled receptors (GPCRs).
There are currently six known LPA-receptors in mammals known as LPA1-6, which are
encoded by distinct genes named LPAR1-6 in humans and Lpar1-6 in mice and chick.
These LPA-receptors play a pivotal role for cell proliferation, migration, angiogenesis,
cytoskeletal changes, actin stress formation and cytokine and chemokine secretion (van
Corven et al., 1989; Amano et al., 1997; Rivera‐Lopez et al., 2008; Sumida et al., 2010)
and activate multiple G proteins, particularly G12/13, Gi, Gq, and Gs. Additionally, LPA is
abundantly expressed in central and peripheral nerve tissues (Sato et al., 2005; Tanaka et
al., 2004; Tanaka et al., 2006).
LPA is produced from activated platelets, activated adipocytes, neuronal cells,
and other cell types. There are at least two major pathways of LPA production. The first
pathway is cleavage of Lysophospholipids (LPLs), for instance lysophosphatidylcholine
(LPC) and lysophosphatidylserine (LPS), by lysophospholipase D/autotaxin. The second
pathway involves hydrolysis of phosphatidic acid (PAs) by phospholipase A1 and A2
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(Moolenaar, 2002; Pagès et al., 2001), which has been predicted to play a pivotal role in
cell signaling (Aoki et al., 2008). However, mechanisms of LPA production in neuronal
cell types are not well understood, although it is certain that LPA plays a pivotal role in
many biological processes.
Lysophosphatidic acid plays a role in a host of physiological and pathological
processes. The first known in vivo biological function of LPA was the regulation of blood
pressure (Sen et al., 1968; Tokummura et al., 1978). The nervous system is one the major
regions for LPA receptor expression as it is expressed in the brain at relatively high
concentrations (Sugiura et al., 1999). There has been significant work on gain- and lossof-function for LPA-receptors in the nervous system. LPA-receptors are expressed in
most neural cell types including neural progenitors, primary neurons, astrocytes,
microglia, oligodendrocytes, and Schwann cells (for review, see Noguchi et al., 2009).
LPA signaling has been shown to influence numerous developmental processes in the
nervous system: survival (Kingsbury et al., 2003), growth cone and process retraction
(Campbell and Holt, 2001; Fukushima et al., 2000; Yuan et al., 2003), and proliferation
(Kingsbury et al., 2003). Additionally, the role of LPA influences brain and vascular
development (Estivill-Torrus et al., 2008; Teo et al., 2009), immune response (Ray and
Rai, 2017), and reproduction (for review, see Beltrame et al., 2020). LPA also induces
numerous cellular responses in a variety of cell types such as cell rounding, neurite
retraction, proliferation, intracellular calcium mobilization and much more (Fukushima et
al., 2001). In particular, LPA-receptors can activate Gα12/13 that leads to activation of
GTPase RhoA, thereby signaling cytoskeletal rearrangement and cell rounding (Etienne-
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Manneville and Hall, 2002) that has been demonstrated to be essential for the guidance of
a growth cone.
Additionally, LPA has not been determined to be involved in axon guidance.
However, previous research has demonstrated LPA to cause cultured retinal growth cones
to collapse in the presence of LPA (Birgbauer and Chun, 2010; Fincher et al., 2014). This
growth cone collapse response, where a RGC growth cone interacts with LPA and
retracts (collapses) or steers away from this chemical cue, is similar to what is seen with
other established axon guidance molecules (Schmitt et al., 2006). Thus, LPA could be a
potential novel axon guidance molecule.

1.4

LPA-receptors
Lysophospholipids (LPs), such as sphingosine 1-phosphate and lysophosphatidic

acid are membrane-derived bioactive lipid mediators. Since the 1990s and early 2000s,
identification of GPCRs has provided researchers with the framework to understand how
LPs signal receptor-mediated functions. Many of the LP receptor genes have been
identified as EDGs (Endothelial Differentiation Genes). In general, LP receptors share
high amino acid similarities while also sharing similarities between GPCRs that signal
other bioactive lipids such as endogenous cannabinoids or platelet-activating factor (for
review, see Fukushima et al., 2001). It is now known that there are six bona fide LPAreceptors (LPA1-6), five of which are high-affinity cognate receptors (LPA1-5).
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1.5

LPA Receptor-1
LPA1 is the first receptor identified for its high affinity to LPA (for review, see

Fukushima et al., 2001; Ishii et al., 2004). The mammalian (human, mouse, and rat)
genes encode 41-kDA proteins consisting of 364 amino acids. LPA1 activates three of the
major LPA pathways: Gαi/o, Gαq/11, and Gα12/13 (Fukushima et al., 1998; Ishii et al., 2000).
There is high expression of Lpar1 in adult mice, which is found in brain, uterus, testis,
lung, heart, and many other regions of the adult mouse (Contos et al., 2000; Ye, 2008).
During embryonic development, Lpar1 is enriched in the brain and retina (Ohuchi et al.,
2008; Fincher et al., 2014) which has led to its focus as an important mediator in the
developing nervous system. Lpar1 was found to be expressed in oligodendrocytes (CNS)
and Schwann cells (PNS) that serve as the myelinating cells of the nervous system
(Weiner et al., 1998; Weiner and Chun, 1999).
The attempts at targeted disruption of Lpar1 in mice resulted in several in vivo
functions of this receptor (Contos et al., 2000). Lpar1(-/-) mice had nearly 50% lethality
during the perinatal period, and ones that survived had reduced body size, craniofacial
dysmorphism, and increased apoptosis in sciatic nerve Schwann cells (Weiner et al.,
2001; Contos et al., 2000).

1.6

LPA Receptor-2
Lpar2 was first identified because of its homology with Lpar1 while investigating

orphan GPCR genes, where it was revealed that Lpar2 had nearly 60% amino acid
homology as Lpar1. LPA2 is a bona fide LPA receptor because it demonstrates high
affinity for LPA (Bandoh et al., 2000). Similar to LPA1, LPA2 couples with three G-
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proteins, Gαi/o, Gα11/q, and Gα12/13. These various signals activate cellular events that
include Ras, mitogen-activated protein kinase, Rac, diacylglycerol, and Rho (Fukushima
et al., 1998). In chick, RT-PCR data shows that Lpar2 is expressed the developing brain
and retina (Fincher et al., 2014). In mouse, the regions of high expression for Lpar2 is in
kidney, uterus, and testis while moderately expressed in lungs. Additionally, it has lower
expression levels in brain, heart, spleen, stomach, and thymus (Contos et al., 2000). In
humans, LPAR2 is predominantly expressed in testis and leukocytes. Of issue is that in
cancer cells, LPAR2 expression was found in several cases, which may indicate a role for
mediating tumor growth for LPA2 (An et al., 1998).

1.7

LPA Receptor-3
Similar to Lpar2, Lpar3 was discovered as an orphan GPCR by the use of

degenerate PCR-based cloning and searches for homology (Bandoh et al., 1999). The
most abundant expression of human LPAR3 is in heart, testis, prostate, pancreas, lung,
ovary, and brain (Bandoh et al., 1999; Im et al., 2000), whereas in mice high expression
is found in testis, kidney, lung, small intestine, heart, stomach, spleen, brain, and thymus
(Contos and Chun, 1998). In chick, RT-PCR data shows that Lpar3 is expressed the
developing brain and retina (Fincher et al., 2014). Similarly, with LPA1 and LPA2, LPA3
couples with Gαi/o and Gαq to signal phospholipase C activation, Ca2+ mobilization,
adenylyl cyclase inhibition or activation, and mitogen-activated protein kinase activation
(Ishii et al., 2000). Importantly, LPA3 does not appear to couple with Gα12/13 to signal
Rho, which in turn, did not mediate cell rounding in neuronal cells and an explanation for
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why LPA3 is not involved in LPA-induced growth cone collapse (Ishii et al., 2000;
Birgbauer and Chun, 2010).

1.8

LPA Receptor-4
The identity of LPA4 was originally from cloning of a putative receptors that were

GPCRs (O’Dowd et al., 1997; Janssens et al., 1997) and was later established to have a
specific affinity for LPA by ligand screening (Noguchi et al., 2003). Interestingly, LPA4
is more closely related to P2Y purinergic receptors instead of the typical homology
shared between LPA and S1P receptors. The unique characteristic of LPA4 is that P2Y
purinergic receptors, which are GPCRs, are activated by nucleotides and nucleotide
sugars. Meanwhile, LPA4 did not respond to any nucleotides or nucleosides (Janssens et
al., 1997; Noguchi et al., 2003). LPA4 has a specific affinity for 18:1-LPA and following
18:0-, 16.0, 14:0, and 1-alkenyl-LPA, respectively (Noguchi et al., 2003). However, there
was not specificity for other lipids such as S1P or SPC (Noguchi et al., 2003).
In humans, expression of LPAR4 is abundantly expressed in ovary and is
moderately expressed in brain, heart, small intestine, testis, prostate, colon, thymus, and
pancreas (Noguchi et al., 2003). The predominant areas of expression in mice for Lpar4
is in heart, skin, thymus, ovary, developing brain, and embryonic fibroblasts (Lee et al.,
2008; Lee et al., 2007). Importantly for this research, RT-PCR data shows expression of
Lpar4 in the developing chick brain and retina (Fincher et al., 2014).
In LPA4 expression studies in cells, LPA induces cell rounding and stress fiber
formation by activating the Gα12/13 and Rho/Rho-kinase pathways (Lee et al., 2007;
Yanagida et al., 2007) that is also found for cells expressing LPA1, LPA2, and LPA5. It
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has been reported that targeted disruption of LPA4 leads to embryonic lethality caused by
disorganized blood and lymphatic vessels but not fully penetrant, as some animals do
survive (Sumida et al., 2010). Also, Takara et al., (2017) found that LPA4 induces
enhanced vascular network information and improves drug delivery into tumors that led
to anti-tumor effects.

1.9

LPA Receptor-5
The orphan GPCR, GPR92, was identified as LPA5 by its binding affinity to LPA

(Kotarsky et al., 2006) and couples with Gα12/13 and Gq as well as increases cAMP levels
(Lee et al., 2006). Structurally different from LPA1-3, LPA5 is also part of the P2Y
(rhodopsin-GPCR) family like LPA4, which it shares 35% homology with LPA4 (Lee et
al., 2006). Expression studies from murine tissue find Lpar5 in embryonic brain, small
intestine, skin, spleen, stomach, thymus, lung, heart, and liver (Kotarsky et al., 2006; Lee
et al., 2006). In LPA5 expressing cells, LPA has shown to induce neurite retraction and
stress fiber formation by activating the Gα12/13 and increases intracellular calcium levels
via Gαq (Lee et al., 2006). Interestingly, two other lipid-derived molecules (farnesyl
pyrophosphate and N-arachidonylglycin) were found to bind to LPA5 (Oh et al., 2008).
This study suggested that the two ligands have a different interaction with the bindingpocket of LPA5. However, successive studies confirmed LPA5 to be a bona fide LPAreceptor because of the ligand-receptor interactions with 18:1-LPA (Williams et al.,
2009; Yin et al., 2009).
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1.10

LPA Receptor-6
LPA6 is a newly identified GPCR of LPA and is closely related to LPA4.

Yanagida et al., (2009) presented the case for LPA6 because of its high sequence
homology with LPA4, thus suggesting that LPA might be its ligand. Curiously, Yanagida
et al., (2009) could not detect LPA-induced Ca2+ mobilization or cAMP level changes in
their B103-p2y5 (rat neuroblastoma-LPA6) cells. However, since the validation of LPA6
as an LPA receptor, LPA6 has been reported to be associated with several types of tumor,
such as colorectal (Takahashi et al., 2017; Katkoori et al., 2012), liver (Mazzocca et al.,
2015; Sokolov et al., 2013), prostate (Ketscher et al., 2014), pancreatic cancer (Ishii et al.,
2015), and breast cancer (Tao et al., 2019). However, the role of LPA6 remains to be
controversial since previous studies indicated that LPA6 might act as a tumor suppressor
and inhibit migration, whereas others found LPA6 might act as a tumor facilitator
(Takahashi et al., 2017; Katkoori et al., 2012; Mazzocca et al., 2015; Sokolov et al.,
2013; Ketscher et al., 2014; Ishii et al., 2015).

1.11

LPA – A potential axon guidance molecule
There has been a considerable amount of work investigating axon guidance

molecules. At this point, there are many proteins that are established axon guidance
molecules such as Ephs and ephrins, wnts, semaphorins (for review, see Erskine and
Herrera, 2007). A hallmark for establishing inhibitory axon guidance cues is by its ability
to induce growth cone collapse such as semaphorins. Recent evidence suggests a new
class of signaling molecules might be potential axon guidance cues, which are
Lysophospholipids (LP). One type of LP that has shown promise is lysophosphatidic
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acid. Jalink et al., (1993) found that LPA caused growth cone collapse and neurite
retraction in rat pheochromocytoma (PC12) cells. Additional studies were also able to
find similar effects by LPA on primary embryonic retinal axons in vitro from chick,
Xenopus, and mouse (Fincher et al., 2014; Strochlic et al., 2008; Birgbauer and Chun,
2010). The in vitro evidence is strengthened by the fact that Lpars1-4 and -6 are
expressed in the developing chick retinal tissue (Fincher et al., 2014) and a structurally
similar lipid sphingosine 1-phosphate (S1P) has been verified axon guidance molecules
(Strochlic et al., 2008). Additionally, Birgbauer and Chun (2010) analyzed knockouts for
Lpar1-3 in mice and found that Lpar1-3 were not required for cultured RGC growth cone
response to LPA. Since Lpar1-4 and -6 are expressed in retina, the evidence is suggestive
either Lpar4 or -6 as the mediator for RGC growth cone collapse in culture. However,
based on ligand-receptor affinity assays, LPA6 has a low-affinity for LPA binding (Lee et
al., 2009; Yanagida et al., 2009) which justifies Lpar4 as being the best candidate for
mediating growth cone collapse for LPA.

1.12 Assays for studying axon guidance
In vitro assays are important tools for investigating what molecules are assisting
with neuronal connections to establish the brain during development. Additionally, in
vitro studies provide a controlled environment during experimentation. The benefits of in
vitro experiments include (1) working with an identified cell type, (2) the ability to test
individual potential axon guidance molecules, especially when a molecule demonstrates
repulsive cue-like qualities, and (3) the ability to observe growth cone motility and
protein dynamics by live cell imaging. There are two common cell types that are used in
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in vitro studies which are retinal ganglion cells and spinal cord neurons (dorsal root
ganglion cells) in chicken, mouse, and Xenopus (Fincher et al., 2014; Gomez et al., 2003;
Luo et al., 1993).

1.13

Experimental Model for LPA4
The aim of this thesis was to develop a CRISPR system to mutate Lpar4 in the

developing chick retina to give a better understanding of how LPA mediates growth cone
collapse of retinal ganglion cells, in hopes to better understand axon guidance. Chicken
embryonic retinas are easily accessible which makes them an excellent model for study.
Based on several studies, the evidence suggests that LPA may be a novel axon guidance
molecule (Fincher et al., 2014; Birgbauer and Chun, 2010). The study by Birgbauer and
Chun (2010) suggests that LPA1-3 are not key for LPA-induced growth cone collapse,
while LPA5 is not expressed in the developing chick retina (Fincher et al., 2014) and
LPA6 has a low affinity for LPA (Yanagida et al., 2009). Therefore, we hypothesize that
LPA4 is the receptor that signals growth cone collapse in the presence of LPA. In order to
investigate the in vivo role of LPA and axon guidance, we needed to establish a method
for targeting LPA4.
Genetic engineering for in vitro or in vivo studies has provided important insights
into a plethora of receptor-ligand interactions. Specifically, CRISPR-Cas9 has been
making groundbreaking advancements for gene-editing (for review, see Doetschman and
Georgieva, 2017). CRISPR-Cas9 is establishing itself as the designer nuclease because of
its ability to only require a short single-guide RNA (gRNA), which makes it target
specific. For this research, CRISPR was designed to induce a double-stranded break to

P a g e | 14

DNA, thereby introducing short insertions or deletions at the cleavage site to make a nonfunctional LPA4.
To accomplish this, we used a technique known as electroporation that will insert
DNA/RNA into stem/progenitor cells of the developing chicken retina (Islam et al.,
2012). The pulsed electric field will increase cell membrane permeability, and therefore,
allowing for molecules that would not have been readily taken up by cells can now be
introduced into the cellular environment. Due to the wide range of applications for
electroporation (Neumann et al., 1982; Islam et al., 2012), the parameters can be vastly
different: amplitude, duration, pulse number, and repetition rate. As such, we followed
the same parameters established by Islam et al., (2012) to transduce plasmids into the
developing chick retina. By combining our CRISPR system and electroporation, this
research looks to investigate whether LPA4 is the receptor responsible for mediating
LPA-induced growth cone collapse, to determine whether LPA is required for guiding
and establishing the highly specific organization of visual neurons that govern axon
pathfinding.
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Chapter 2

2.1

MATERIAL AND METHODS

Design of gRNAs
We designed the oligonucleotides used as the gRNA in our CRISPR system

through the MIT CRISPR website (http://crispr.mit.edu). It is a web based CRISPR
design tool to simplify the selection process for a CRISPR guide sequence in a DNA
input.
From the gRNA sequences recommended by the MIT CRISPR algorithm, we
added our own selected measures for our gRNAs (criteria based on Gandhi et al., 2017).
First, we selected a sequence of 19 to 20 nucleotides in length and adjacent to an NGG
proto-spacer motif (PAM) sequence. Second, and critically important, we compared the
homology of our gRNA sequences to other Lpar genes to limit off-target effects. Lastly,
we took into consideration of the gRNA targeting the locus at the 5’ or 3’ direction.
Oligonucleotides were ordered from Eurofin Genomics as forward and reverse primers
and annealed to produce double-stranded oligos. The annealed oligos were ligated into
BsaII linearized U6.3>gRNA.f+e vector (Gandhi et al., 2017; addgene: 99139) (provided
by Marianne Bronner) at the of the 5’ and 3’ overhangs.

2.2

Ligation Reaction
The plasmid supplied (U6.3>gRNA.f+e; addgene: 99139) was linearized with

Bsal-HF with either 5’-GGAT-3’ or 3’-CAAA-5’ overhangs thus allowed us to clone in
our annealed oligos into our vector. The ligation reaction incubated for 20 minutes at
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room temperature (25-27°C). After incubation, high-efficiency 5-alpha Competent E. coli
(DH5α; New England BioLabs) were transformed with the ligated gRNA vector.

2.3

Transform Competent E. coli Cells
High Efficiency Competent E. coli were transformed with the newly ligated

gRNA vectors. SOC Medium is used during the transformation procedure. E. coli cells
are spread on pre-warmed LB agar plates containing 100 µg/ml carbenicillin. The LB
concentration for 500 ml was 5 g Tryptone, 2.5 g Yeast extract and 5 g NaCl. An efficient
ligation reaction produced over a hundred colonies in total, which we diluted our
transformation mixture to reduce the total number of colonies for screening.

2.4

Plasmid Isolation
To screen for successful inserts, we isolated plasmid DNA using Zymoresearch

miniprep plasmid DNA purification kit. Transformed E. coli were left to grow in LB
medium overnight. To determine if our oligos ligated into our vector, we PCR-amplified
using U6 sequencing primers (5’-ATCGGCTAAGCGGGCCTAAG-3’) with gRNA
reverse primers (Table 1). At this point, we confirmed that five of the gRNAs oligos were
successfully cloned into the U6.3>gRNA.f+e vector. However, gRNA6 was not
successfully cloned. Taken together, our newly cloned gRNA vector was ready to be used
in the transfection protocol or to be stored at -20°C for later use.
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Table 1: Single-stranded DNA oligonucleotides with overhangs used to ligate into
U6.3>gRNA.f+e. vector that will target Lpar4.
gRNAs
gRNA 1
gRNA 2
gRNA 3
gRNA 4
gRNA 5
gRNA 6

2.5

gRNA Oligos
F 5’- GGATGGTTCCGGTCTCGTACCATT-3’
R 5’- AAACAATGGTACGAGACCGGAACC-3’
F 5’- GGATGTAATGGTACGAGACCGGAA-3’
R 5’- AAACTTCCGGTCTCGTACCATTAC-3’
F 5’- GGATGGGTCCTAATGGTACGAGAC-3’
R 5’- AAACGTCTCGTACCATTAGGACCC-3’
F 5’- GGATGGAACGGATAGACTATTGCA-3’
R 5’- AAACTGCAATAGTCTATCCGTTCC-3’
F 5’- GGATGTGCAATAGTCTATCCGTTC-3’
R 5’- AAACGAACGGATAGACTATTGCAC-3’
F 5’- GGATGCCTTTAAGTACAACCTGTA-3’
R 5’- AAACTACAGGTTGTACTTAAAGGC-3’

Basepair length
25 bp
25 bp
25 bp
25 bp
25 bp
25 bp

Cell culture, and transfection of DF1-Cas9 Cells
An immortalized chicken DF-1 fibroblast cells expressing Cas9 (DF1-Cas9;

Gandhi et al., 2017) was obtained. The DF1-Cas9 cells were cultured at 37 °C in 5% CO2
in DMEM (Hyclone) supplemented with 10% fetal bovine serum (Gibco) and
penicillin/streptomycin (Hyclone). To test gRNAs, DF1-Cas9 cells were transfected with
each of the previously cloned gRNAs. The DF1-Cas9 cells were seeded to be 80%
confluent on the day of transfection. We used the cationic lipid-based FuGene-HD
reagent (Promega). The DNA was added to a mixture with the FuGene-HD reagent in a
4:1 ratio of FuGene-HD to plasmid DNA. We incubated our mixture for 10 minutes, and
it was added to our cells and cells grew for 2 days before analyzing our transfected cells
under fluorescence microscopy. After analysis, transfected cells were washed with sterile
PBS.
P a g e | 18

2.6

Cell Sorting
For analysis via cell sorting, the DF1-Cas9 cells were first harvested from their

culture dish via Trypsin for 5 minutes at 37°C. The cells were washed twice with PBS
with a centrifugation step in between for 5 minutes at 1500rpm. Cells were resuspended
in phosphate buffered saline (PBS) (Invitrogen) with 0.5% fetal bovine serum (FBS) and
0.1 mM EDTA at 1000 cells/µl (recommended by Nanocellect WOLFsorter). The cells
were then filtered (50 µm) to remove aggregated cells and then stored on ice. Cell sorting
was done following Nanocellect WOLFsorter manufacturer protocol. Each of the
gRNA/tdTomato transfected cells were left on ice before DNA isolation.

2.7

DNA Isolation of tdTomato-positive Cells
Sorted cells were pelleted via centrifugation for 10 minutes at 3600 rpm and the

supernatant was removed. The pelleted tdTomato-positive cells were resuspended in a
cell lysis solution (100 mM TrisCl, pH 8, 50 mM EDTA, 1% (w/v) sodium dodecyl
sulfate) until viscus. The cell lysate was centrifugated at max speed for 3 minutes and the
supernatant was transferred into a 1.5 ml Eppendorf containing 600 ul of isopropanol,
mixed well, followed by a max centrifugation step for 1 minute at room temperature.
Supernatant was removed and pellet washed with 70% EtOH followed by max speed
centrifugation for 1 minute. Supernatant was removed and the DNA pellet was air dried.
DNA was resuspended in nuclease-free H2O and incubated overnight at room
temperature to solubilize genomic DNA before PCR-amplification.
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2.8

PCR over Lpar4
Primers were designed for PCR using the Lpar4 genomic sequence UCSC

Genome Bioinformatics website (NM_001278049 and chr4:13745611388213) and
NCBI’s Primer-Blast, (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Using the
following criteria: 1) the primers must have a Tm>55°C, and 2) The length of them
should be between 18 and 22 base pairs and have a 45 to 60% GC content. Table 2 shows
the forward and reverse primer target locus and the expected amplicon of PCR
production for the single exon encoding Lpar4.

Table 2. Design of primer to PCR-amplify over Lpar4 exon from genomic
DNA of transfected DF1-Cas9 tdTomato-positive cells

PCR Target
Lpar4 locus

2.9

Forward and Reverse Primer
5’-ACCTGCATCAGCGTTGACCG-3’
3’-ACAGGTGGTGCTGGTGTTGG-3’

PCR product size
296 bp

Genotyping
Transfected cell DNA was used for PCR amplification using Q5 High Fidelity

with Lpar4 locus primers. Amplicons were then purified (Zymo) and TA cloned into
CloneJET PCR Cloning Kit (ThermoFisher) transformed into E. coli, clones selected,
plasmid prep by miniprep and sent off for sequencing at Eurofins Genomics.

2.10

Animals
Fertilized chicken eggs were obtained from Tyson Farms. Eggs were incubated at

39°C with rocking and humidity for 2 days until experimental procedures.
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2.11

Ex ovo Cultured Transfer
Solo number 7 plastic cups were weighted with 35 mL of sterilized distilled-H20

before a 4 cm-deep plastic hammock with Saran brand plastic wrap was made and
secured with a rubber band. Cup lids were given single puncture for air flow and the cups
and lids were UV sterilized for 90 minutes. On embryonic day two (E2), embryos were
ex ovo cultured in the plastic cups by cutting an opening to carefully transfer entire
contents of eggs into ex-ovo cups and placed into 39°C incubator with water for
humidity.
2.12

Injections and Electroporation
Embryos in ex ovo culture were injected into the subretinal space with GFP and

tdTomato plasmids using 0.05% fast green to visualize injection and electroporated at
embryonic day-3 using a BTX ECM 830 Electroporation Generator System that was set
to 5 pulses of 15V for 50 ms with 950 ms intervals as previously described (Islam et al.,
2012). For co-electroporation experimentation, the concentration of GFP plasmid was at
2.9 μg/μL and tdTomato 1.2 μg/μL. For Lpar4 knockout experiments, the subretinal
space was electroporated with 2 μg/μL CAGG> nls-Cas9-EGFP, 1.5 μg/μL U6.3 >
Lpar1gRNA1 and 1.5 μg/μL tdTomato. Electroporated embryos were allowed to develop
until embryonic day 6 until retinal dissections described below.
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2.13

Retinal Dissection, Imaging, and Retinal Culture
Retinas were dissected by removing the iris to expose the retina from

electroporated embryos on embryonic day 6 (Hamburger and Hamilton stages 28–29)
under a fluorescence stereoscope. The fluorescent retinal was isolated, flat mounted on a
slide in 90% glycerol, and prepared for confocal imaging using an Olympus FV1000
laser-scanning confocal microscope.
The fluorescent retinal tissue was cut into explants. Explants were cultured in
Ham’s F12 media (Hyclone) supplemented with N2 and B27, 1 mM sodium pyruvate, 0.5
mg/ml ascorbic acid, 10 ng/ml CNTF, 50 ng/ml BDNF, and penicillin-streptomycin in a
37°C, 5% CO2 incubator. After overnight incubation on 0.1 mg/ml poly-D-lysine and 10
µg/ml laminin-coated dishes, cultures were fixed in 4% paraformaldehyde.
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Chapter 3

RESULTS

We have designed a CRISPR-Cas9 system that mutates Lpar4 at early developmental
stages to target retinal ganglion cells, starting with cloning of gRNAs to demonstrate
proof of principle while optimizing delivery of plasmids into the developing chick retina.
3.1

Designing gRNAs for Lpar4 mutations in chick embryos
We designed guide RNAs (gRNAs) that targeted the coding sequence of Lpar4.

By obtaining sequencing data for Lpar4 locus
(http://www.ncbi.nlm.nih.gov/nuccore/XM_015278221.2), we knew that LPA4 is
produced by a single exon, which meant that we could not target intron-exon boundaries.
Therefore, we made the decision to target the first half of Lpar4 coding sequence to
increase our chances of a mutation that would result in a non-functional LPA4. If we had
targeted the second half of the Lpar4 coding sequence, it might be possible to produce a
functional LPA4. It was important that we had two validated gRNAs that have high
mutation frequency for our in vitro assays so we could compare whether two gRNAs
produce the same growth cone collapse data. If the data was similar, then we would be
confident that LPA4 is mediating LPA-induced growth cone collapse rather than an offtarget effect from our gRNA.
The web based CRISPR design tool allows for simplifying the selection process
for a CRISPR guide sequence. It identifies any sequences similar to other targets while
highlighting gRNAs with high specificity. When presented with multiple gRNA
sequences, we checked homology between the other LPA-receptors. What we found is
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that there are multiple regions with high homology (Li et al., 2009), and are region of
interest were areas of minimal homology. By pinpointing regions with the least
homology, we were confident that off-target effects for the other LPA-receptors would be
rare. We did have our sights on targeting a region where LPA is predicted to bind;
however, there was high homology between the other LPA-receptors (Li et al., 2019). In
addition to our own gRNA design parameters, Marianne Bronner’s lab provided us with
their own gRNA selective measures that would reduce off-target effects and improve
gRNA efficacy in the developing chick (a CGG or TGG PAM sequence; Gandhi et al.,
2017). At this point, we were confident with our approach before importing our Lpar4
sequence into the MIT CRISPR Program for preliminary gRNA selection, while
considering the guidelines provided by Marianne Bronner’s lab. We were able to select
six gRNAs that fit our criteria (Fig. 1). Oligonucleotides for Lpar4 guide sequence were
ligated into our vector and transformed into E. coli competent cells. Our vector
(U6.3>gRNA.f+e.) has a chicken U6 promoter (U6.3) and has a modified gRNA ‘F+E’
scaffold that contains a ‘flipped’ (F) Adenine-Uracil downstream of the protospacer and
an ‘extended’ (E) Cas9 stem handle to improve RNA polymerase III-mediated gRNA
transcription that will help stabilize the interaction between Cas9 and gRNA (Gandhi et
al., 2017).
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A)

B)

Figure 1. Design of gRNAs to mutate Lpar4 using the MIT CRISPR Program. (A)
The seed sequences for each of the selected gRNAs to target Lpar4. (B) Protein
sequence of chicken LPA4 with yellow regions indicating GPCR transmembrane
domains. Light blue arrows indicate guide RNA target sequences and arrow direction
is related to direction of targeted DNA sequence (5’ or 3’) (Fig. 1B, adopted from
Eric Birgbauer).

To verify whether we had successful clones, we tested for inserts by colony PCR
using U6 sequencing primers and gRNA reverse primer producing a 176 bp product (Fig.
2). Up to this point, we confirmed that five of the gRNAs oligos were successfully cloned
into the U6.3>gRNA.f+e vector. However, gRNA6 was not successfully cloned. Taken
together, our newly cloned gRNA vector was ready to be used to be validated for
CRISPR mutation.
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Figure 2. Agarose gel electrophoresis of
successfully cloned gRNAs colonies
after PCR-amplification. Testing for
successful ligation of U6.3>gRNA.f+e.
vector with annealed gRNA primers was
done using U6 sequencing primers with
gRNA reverse primers. Indicated in
lanes 1-5 are gRNAs 1-5, respectively.
PCR products are 176 bp and the MW
marker is indicated by MW with bands
at 200 and 100 bp.

3.2

Transfection of DF1-Cas9 cells, sorting of tdTomato-positive cells, DNA

isolation for PCR-amplification of Lpar4
By using an immortalized chicken fibroblast cell line that expresses Cas9 (DF1Cas9; Gandhi et al., 2017), we wanted test our gRNAs on Lpar4. We co-transfected
tdTomato with our gRNA plasmid because our gRNA plasmid did not have a marker for
analyzing transfection (Fig. 3), which tdTomato also served as a mechanism for selecting
our gRNAs cells by cell sorting. We optimized our transfection ratio from 3:1 to 4:1
(FuGene-HD: plasmid DNA) finding that the 4:1 ratio is significantly better at
transfecting our DF1-Cas9 cells.
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Figure 3. Transfection of
gRNA
and
tdTomato
plasmids into DF1-Cas9
cells. To visualize a
successful
transfection,
cells were imaging via
fluorescence microscopy.
Transfection consisted of
cloned U6.3>Lpar4.gRNA
and tdTomato plasmids .

To be certain that all tdTomato-positive cells were co-transfected with gRNA
plasmid, a 1.5:1 ratio molecules of gRNA plasmid DNA to tdTomato plasmid was used
in the DNA mixture for transfection. It was critical to have a higher concentration of
gRNA plasmid DNA compared to tdTomato to ensure all tdTomato-positive cells
contained gRNA plasmid DNA. We were able to produce were transfection efficiencies
ranged from 6.6 to 17.6% for tdTomato-positive cells (Table 3). Additionally, from prior
cell sorting attempts, efficiency of transfection was vital in order to get a quantifiable
amount of DNA that could be used for PCR-amplification.
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Table 3. Analysis of FACS sorted DF1-Cas9 tdTomato-positive cells. gRNA and
tdTomato plasmids were transfected in DF1-Cas9 cells then were sorted by FACS.

DF1-Cas9 Cells and
gRNA transfected with
tdTomato

Approximate total
number of cells

Number of
tdTomato-positive
cells

Transfection
Efficiency
percentage

Lpar4.gRNA1

3,000,000

539,650

17.9%

Lpar4.gRNA2

3,000,000

294,212

9.8%

Lpar4.gRNA3

3,000,000

319,649

10.6%

Lpar4.gRNA4

3,000,000

198,506

6.6%

Lpar4.gRNA5

3,000,000

245,447

8.2%
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After cell sorting tdTomato-positive cells and DNA isolation, we PCR-amplified
over our targeted Lpar4 region. Gel electrophoresis was to confirm we had PCRamplified over Lpar4 (Fig. 4).

Figure 4. Agarose gel electrophoresis
after cell sorting of tdTomato-positive
cells and PCR-amplified DNA for
Lpar4. Shown in Lane 1 is the MW
marker indicated by 300 and 200 bp,
respectively. Successful PCR products
are shown in lanes 2-6, which are
gRNAs 1 to 5, respectively, and
indicated by PCR product of 296 bp.

We isolated our PCR products and cloned it to isolate plasmids for sequencing. An issue
we ran into was successfully ligating our PCR product into our cloning kit. After multiple
attempts, we were able to successfully ligate our PCR product after increasing our
concentration of product and during cloning. We followed the CloneJet transformation
protocol and we were able to produce a high number of transformants. Transformants
were grown overnight and plasmid DNA was isolated following ZymoResearch miniprep
plasmid DNA protocol. We sent off plasmid DNA for sequencing to Eurofin Genomics.
A range of different deletions were identified from each of the gRNAs (Fig. 5). What we
found that gRNA 1 produced mutations 7 out of 7 sequences, gRNA 2 had 8 out of 8 and
both gRNAs had mutations ranging from 2 bp to 20 bp deletions, whereas gRNA 3 had a
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mutation 4 out of 6 sequences. Sequence results for gRNA 4 and 5 have not been
analyzed due to trouble shooting issue when prior sequencing attempts were done, but
analysis of gRNA 4 and 5 may be done in the future. Furthermore, the mutation events
we analyzed from gRNA 1 and 2 were unique, which indicated that the mutation events
we sequenced were independent from each other and were not from the clones. Taken
together, these results confirm that we have designed robust gRNAs that mutate at the
precise Lpar4 locus as expected.

Figure 5. CRISPR-Cas9mediated mutation of Lpar4
from transfected DF1-Cas9
cells. Shown in red lettering is
the normal DNA sequence of
Lpar4. Below is the sequence
of individual colonies from
our transformed gRNAs. The
number of excised nucleotides
is represented in (bp).
Mutations from gRNA 1
reveal that all sequence results
had a mutation of various
sizes, which was also found
from gRNA 2 sequences.
Lastly, gRNA 3 did not
produce mutations in every
sequence.
Dashed
lines
represent excised nucleotides.
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3.3
Optimization of injection and electroporation into the subretinal space of the
chick retina
Before injecting our CRISPR system into the chick retina, we needed to demonstrate
that our methodology of injection and electroporation could transduce retinal ganglion
cells. Additionally, we needed to validate that co-electroporating multiple plasmids could
be introduced into the same cell. We injected tdTomato and GFP plasmids into the
subretinal space of the chick embryo as shown in figure 6 using fast green to visualize
injections. Initial retinal injections were done into the retinal cavity, which only
transduced a few retinal cells (data not shown). Islam et al., (2012) established that it is
important to inject into the subretinal space for transducing retinal cells.

Figure 6. Visualization of a chicken embryo at day-3 under a stereoscope to locate the
retina. (A) Chick embryo before injection into the subretinal space. (B) A successful
injection of plasmids into the subretinal space and fast green is included to visualize
injection.
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For our injection procedure, embryos were cultured ex ovo at Hamburger and
Hamilton (HH) stages 6-10. At HH15-18, we injected a GFP and tdTomato plasmid into
the subretinal space and transduced via electroporation (Islam et al., 2012). Three days
later, retinal tissue was analyzed for transduction of GFP and tdTomato. We went
through many trials of optimizing our injections and electroporations. Initially, our
plasmid concentration was 800 ng/µl which is when we were unable to find transduced
retinal tissue. After increasing our plasmid DNA concentrations to above 1.5 µg/µl we
had a robust increase in the area of retina that was transduced (Fig. 7). We were able to
transduce a substantial portion of the retina (Fig. 7B and C).

Figure 7. Fluorescence stereoscope examination of isolated embryonic day-6 retinal
tissue to visualize co-electroporation of tdTomato and GFP plasmids in embryonic
chick retina. A) Flat mounted E6 retina under brightfield to visualize retina. (B to C)
Same orientation as (A) but under the red channel (B) or green channel (C) to visualize
where the plasmid transduction was localized in the retina. Overall, co-localization
seems apparent between tdTomato and GFP plasmids in the chick retina.

To confirm that the retinal tissue had been co-electroporated with both plasmids
into the same cells, we examined our retinal tissue via fluorescence confocal microscopy.
Before confocal imaging, isolation of GFP/tdTomato retinal tissue was excised and flat
amounted on a microslide slide. Confocal imaging revealed high transduction of GFP and
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tdTomato labeled retinal cells (Fig. 8A and B). Next, we asked whether the GFP and
tdTomato were expressed in the same retinal cells by overlaying the images (Fig. 8C)
Importantly, the retinal tissue isolated was injected with a 3:1 ratio of GFP to tdTomato
plasmids, so we predicted that there would be a higher number of GFP expressing cells.
We found that almost all the tdTomato-positive cells expressed GFP (i.e., indicated by
orange-yellow cells) (Fig. 8C). Confocal analysis demonstrated that we are able to
transduce multiple plasmids into the same cells at early developmental stages in the
retina.

A

C
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B

Figure 8. Confocal imaging to
visualize co-transfection of plasmids
at the cellular level. Imaging was done
at 40x to enhance view of tdTomato
and GFP co-electroporated retinal
cells from embryonic chick. A)
Visualization of GFP and (B)
tdTomato transduced retinal cells. C)
Overlay of same orientation taken for
(A and B) to analyze co-transfection
efficiency.

In order to demonstrate that RGC growth cones could be transduced, we proceeded
to do explant cultures on our transduced retinal tissue. Isolated retinal tissue was cut into
explants and cultured overnight. We observed RGC growth cones could be transduced
(Fig. 9B). One of the issues we found was being able to produce a substantial number of
growth cones that expressed GFP. The way we overcame this issue is by increasing the
concentration of plasmid DNA during retinal injections. These results provide us with
confidence that our technique of retinal injection with electroporation will produce RGC
growth cones that can be analyzed.

Figure 9. Electroporated E6 chick retina in culture and imaged under fluorescence
microscopy to identify GFP expressing RGC neurites. A) Visualization of retinal explant
and RGC neurites branching from the explant. B) An individual RGC axon and tipped by a
growth cone (white arrow), thus demonstrating subretinal electroporation can transduce
RGCs.
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3.4

Injection and electroporation of CRISPR-Cas9 construct with tdTomato into

the subretinal space of the developing chick retina
Once we established proof of principle for our CRISPR gRNAs and cultured
transduced explants, we were ready to introduce our CRISPR-Cas9 construct into the
embryonic chick retina. Transduction into RGCs has been established (Fig. 7 and 8;
Islam et al., 2012), in addition to RGC growth cones (Fig. 9). Recent attempts to
introduce our CRISPR system were unsuccessful due to an issue with embryo viability.
As a result, future attempts will be conducted.
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Chapter 4

DISCUSSION

LPA is an extracellular signaling molecule that has demonstrated its potency to be
a potential repulsive-like axon guidance molecule. These effects have been shown in
many neuronal cell types and in primary neurons (Jalink et al., 1993; Kozma et al., 1997;
Tigyi et al., 1996a and b; Fincher et al., 2014; Birgbauer and Chun, 2010). The effect of
LPA on growth cone collapse is present at the nanomolar range and activates neurite
retraction via the Rho pathway. There are several GPCRs that LPA signals (LPA1-6).
Previous research has attempted to identify which receptor is responsible for mediating
neurite retraction in mice and determined that LPA1-3 were not required (Birgbauer and
Chun, 2010). During that time, LPA4 and LPA5 were recently identified (Noguchi et al.,
2003; Kotarsky et al., 2006; Yanagida et al., 2009) making them likely candidates for
mediating LPA-induced growth cone collapse. However, based on RT-PCR data from
embryonic chick retina, we know that LPA5 is not expressed in the retina (Fincher et al.,
2014). More recently, LPA6 has been shown to be expressed in the developing mouse
brain (Suckau et al., 2019), although it was found to have a much lower affinity for LPA
than the other LPA receptors (Yanagida et al., 2009). Accordingly, we chose to target
LPA4 as the receptor mediating LPA-induced growth cone collapse.
Despite the increasing specificity of CRISPR-Cas9 technology, there are still
some important considerations requiring comprehensive studies. Specifically, gRNAs
have tended to have mismatch tolerance, which is when Cas9 cleaves off-target sites for
sequences that are similar to target genes; hence, off-target effects. Efforts to increase
specificity have been conducted to improve gRNA design, species-specific promoters,
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and optimized delivery methods (Gandhi et al., 2017). In our study, our species-specific
promoter and gRNA target sequences were optimal for our target locus. While following
gRNA design criteria from Gandhi et al., (2017), we ensured that we would have minimal
off-target effects among the other Lpars by targeting a sequence with the marginal
homology (Lee et al., 2009). Furthermore, by using two gRNAs for investigating whether
LPA4 is the receptor responsible for mediating LPA-induced growth cone collapse, we
would be confident with our data if it were reproducible.
We have confirmed that our CRISPR system mutates Lpar4 in a chicken cell line.
The effect of our gRNA 1 and 2 supports high efficacy of mutation for Lpar4. We have
not shown the impact of our CRISPR system in a growth cone collapse assay. However,
our CRISPR vectors were specifically designed to be chicken-specific and presented high
efficacy (Gandhi et al., 2017), which makes us confident that our designed CRISPR
gRNAs will mutate Lpar4 in the developing chick retina. Moving forward with growth
cone collapse assays should determine whether our hypothesis that LPA4 is the receptor
that mediates LPA-induced growth cone collapse in vitro.
In addition to validating our gRNAs, we optimized our injections and
electroporations in the developing chick retina. After tweaking plasmid DNA
concentrations, we have resolved that any concentration above 1.5 µg/µl will provide
ample number of transduced retinal cells, and that higher concentrations may transduce
more cells based on preliminary results shown during our attempts at testing various
DNA concentrations. Moving forward, 2.0 µg/µl for Cas9 and gRNA plasmid should be
sufficient with 1.5 µg/µl of tdTomato to ensure the number of molecules of Cas9 and
gRNA plasmids will be more than tdTomato. This is critical when isolation of tdTomatoP a g e | 37

positive retinal tissue takes place so it is certain that it will include both Cas9 and gRNA
plasmid DNA. Our controls during CRISPR experimentation would consist of our control
gRNA plasmid that has a scrambled sequence with no homology for any chick gene,
Cas9 plasmid, and tdTomato. Isolated retinal tissue would be isolated from both Lpar4
and control gRNA and cut into explants and cultured in separate wells. The next day, 1
µM LPA would be added to each well and treated for 10-15 minutes followed by
fixation. Since we are analyzing transduced RGC neurites, we must use fluorescence
microscopy for analysis. To determine whether LPA4 is responsible for mediating LPAinduced growth cone collapse, a growth cone count would be done to calculate the
percentage of collapsed to non-collapsed growth cones. This is the standard method when
doing growth cone collapse assays to determine statistically whether any significance is
found (Birgbauer and Chun, 2010; Fincher et al., 2014). To reduce bias, a blind count
would be done so the person does not know which well contained Lpar4 gRNA.
Besides growth cone collapse data, a data point that we do not have is whether our
gRNAs mutate RGCs. However, the way that we could obtain this data is by cell sorting.
Notably, it has been established that primary murine RGCs are able to be isolated by cell
sorting (Chintalapudia et al., 2017). To move forward with this approach, there are
required factors for the success of isolating transduced retinal cells by cell sorting: 1) sort
efficiency, this would depend on the cell sorter used; 2) optimal combination of
fluorochromes to minimize noise, tdTomato has shown to produce sufficient results; and
3) cell sorting setup. It is also critical to maintain the sample at 4°C when sorting large
numbers of cells (Chintalapudia et al., 2017). Therefore, if we followed our same
injection technique, we could prepare transduced retinal tissue for cell sorting using our
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method for sorting DF1-Cas9 cells. A critical factor is knowing whether many cells has
been collected. If the Trypsin and EDTA steps were done effectively, a cell count via
hemocytometer would serve to quantify cells and indicate whether we have successfully
isolated our retinal tissue into individual cells. What would be expected is that multiple
retinas would be needed to ensure a large quantity of tdTomato-positive cells are
available. The outcome of this experiment would provide proof that our gRNAs mutate
chick retina cells.
There are three possible results from our growth cone collapse data. First, and
based on our hypothesis, we should find Lpar4 mutant growth cones should not collapse
in the presence of LPA. This means that when LPA is added to their environment, we
should find that only a small percentage (10-15%) have collapsed. The reason for 10-15%
is that there are always growth cones that will collapse even without an LPA-treatment
(Birgbauer and Chun, 2010; Fincher et al., 2014). If this were the outcome, we would
assess that LPA4 is the receptor mediating LPA-induced growth cone collapse. Similarly
to Birgbauer and Chun (2010), the second outcome would be that there is still an equal
percentage of growth cones that collapse in the presence of LPA. Indicating that LPA4
does not have a role in LPA-induced growth cone collapse. Lastly, the function of LPA4
may work redundantly with other LPA-receptors to mediate LPA-induced growth cone
collapse. In other words, it is possible that LPA1-4 or -6 are working together to cause
growth cone collapse. Notably, LPA3 was found to not couple with Gα12/13 which is the
pathway for mediating neurite retraction and cell rounding.
If we were to obtain Lpar4 results showing that LPA4 is the receptor responsible
for LPA-induced growth cone collapse, then we would be a step closer to validating a
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new axon guidance molecule. The next question would be to verify how the mutation of
Lpar4 would alter RGC axon pathfinding in vivo. We know that RGCs house their cell
bodies in the retina which then extend their axons through the optic disc to bundle and
form the optic nerve. Already at this early stage of development, guide molecules are
signaling RGC axons as they form the optic nerve. RGC axons from both eyes form the
two optic nerves and grow toward each other where they converge at the optic chiasm, an
x-shaped fiber pathway. The axons continue their contralateral projections to the tectum
where they will find their synaptic targets and form the connections necessary for eye-tobrain communication.
Along the journey for RGC axons, there are a variety to axon guidance cues that
their growth cones will encounter. Some guidance cues have been identified to signal
RGC axons at the midline (chiasm) (for review, see Guillery et al., 1996), whereas other
assist in the organization at the tectum (Luo et al., 1993). If our LPA4 growth cone
analysis presented results that demonstrate this is the receptor responsible for LPAinduced growth cone collapse, we would pursue in vivo imaging. By following RGC
axons along their journey to tectum, we can ask the question: where is LPA mediating
axon guidance? By using our established injection and electroporation method, chick
embryos would develop until embryonic day-9, -10, -12, or -15. Using dye tracing and
light sheet microscopy, the trajectory of RGC axons as they navigate to the tectum would
be analyzed. Since we know that RGCs organize in a highly specific manner in the
tectum, we could visualize whether Lpar4 mutant axons reach their appropriate targets. If
aberrant axons were found in the native contralateral projections, we would hypothesize
that LPA is mediating axon guidance near their synaptic targets. Importantly, autotaxin
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(ATX) — the major enzyme converting lysophosphatidylcholine into LPA — is
expressed in the developing chick brain at HH stage 8 to 36 (Ohuchi et al., 2008). ATX
was expressed in the entire region of the apparent diencephalon as well as in the
hindbrain. Taken together, if ATX is producing LPA in the hindbrain then it is possible
that LPA is mediating axon guidance for RGC axons to not go beyond their target.
If axons were found to go ipsilateral then that would lead us to hypothesize that
LPA is mediating axon guidance at the optic chiasm, which is when RGC axons from
both eyes converge and are signaled to begin their journey contralaterally. Thus, this
would suggest that LPA has a pivotal role for mediating RGCs to extend towards their
native contralateral region. If this was so, we know that RGC axons begin their longjourney between embryonic day-5 and -6. What could be done is using fixed embryos at
various stages where RGC axons reach the optic chiasm to visualize the initiation of RGC
axons projecting both contralaterally and ipsilaterally using light-sheet microscopy. Of
interest, we have labeled RGCs by injecting Alexa Fluor 555 conjugated Cholera Toxin
Subunit B (CTB) (red) into the developing chick retina and visualized their contralateral
projects to where they synapse in the left tectum (unpublished data). Since our CRISPR
system would include tdTomato, our transduced RGC axons would be identified under
red fluorescence. Importantly, we also include our control gRNA plasmid that would
result in normal topographic mapping of RGCs in the tectum. We would use CTB –
Alexa Fluor 496/433 (green) to inject into the non-CRISPR eye to visual those RGC
axons as green. By each eye revealing either green or red RGC axons and Lpar4 mutated
RGC axons began developing ipsilaterally, we might be able to see whether the mutated
RGC axons would synapse in the right tectum. Since we know that the organization of
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RGCs is highly specific (Feldheim and O’Leary, 2010; Rapacioli et al., 2011; Scicolone
et al., 2006; Scicolone et al., 1995), it would be intriguing to determine whether the
ipsilateral projections could successfully synapse in the right tectum. Consequently, if
neural connections were made then the eye-to-brain communication would be distorted.
The next major possible outcome would be that our growth cone collapse assays
would not present the findings that LPA4 is the receptor mediating LPA-induced growth
cone collapse. This would be revealed by a high percentage of collapsed Lpar4 mutant
growth cones when doing LPA treated in vitro assays. These results would be a
continuation to the findings by Birgbauer and Chun (2010), where LPA1-3 in mice did not
alter RGC growth cone collapse. The hypothesis that LPA6 is responsible for mediating
growth cone collapse would then be valid; however, another set of experiments should be
done prior to focusing on LPA6 since it was shown that LPA-binding could only be
detected at high concentrations (Yanagida et al., 2009). The hesitancy to focus on LPA6
is that the concentration of LPA that induces growth cone collapse is present at the
nanomolar range, whereas the binding affinity of LPA6 to LPA is found at the
micromolar range. To this end, we would set our sights on LPA receptor redundancy.
The mechanism of redundancy between one or more LPA-receptors has not been
identified, although it was hypothesized (Birgbauer and Chun, 2010). To investigate
whether multiple LPA receptors are responsible for mediating LPA-induced growth cone
collapse would mean cloning gRNAs for Lpar1-2 and -6. A major reason for not focusing
of LPA3 is because to induce growth cone collapse, or neurite retraction, LPA signaling
uses the Gα12/13 pathway; however, LPA3 does not couple with Gα12/13. The criteria used
for our Lpar4 gRNAs would be considered as well as following the same steps for
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screening gRNA efficacy. There are two ways to approach the question on LPA-receptor
redundancy. 1) We would clone gRNAs into their own plasmid, which would mean
transfecting or injecting an additional plasmid using our current CRISPR system; and 2)
we would clone in another gRNA sequence into gRNA 1 and 2 vectors. This second
method would be optimal since the addition of another plasmid could reduce the
efficiency of our delivery system. It is been established that multiple gRNAs to target
different genes is possible (Sakuma et al., 2014). Intriguingly, Sakuma et al., (2014) were
able to incorporate seven gRNAs and one Cas9 nuclease as a single vector for their
studies. Based on this information, the foremost approach would be to clone in an
additional gRNA to gRNA 1 and 2 vectors for redundancy investigation. There is a
chance that more than two LPA-receptors are mediating growth cone collapse, which
cloning in gRNAs for each of the LPA-receptors into the U6.3>gRNA.f+e. vector could
be done with additional efforts.
If the hypothesis that redundancy is occurring between LPA-receptors, then it
would be necessary to mutate all Lpars and see whether LPA still causes growth cone
collapse. To do so, each of the known LPA-receptors expressed in the developing chick
retina (Lpar1-4 and -6) would need to be targeted. If this did not result in a change for
the percentage of growth cones that collapse or merely a minimal reduction for LPAinduced growth cone collapse, then a possible explanation is an orphan GPCR has yet to
be deemed as an LPA-receptor is mediating growth cone collapse. This outcome would
take measures at doing homology comparisons to known LPA-receptors, LPA binding
assays, and the many other approaches used to classify an LPA-receptor. Still, there is
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much work to be done with the known LPA receptors and investigating which receptor
causes LPA-induced growth cone collapse.
The outcome of this research was to identify a receptor that mediates growth cone
collapse in the presence of LPA. By identifying the receptor responsible for LPA-induced
growth cone collapse, we are providing critical knowledge towards future nerve
regeneration treatments such as treatment for glaucoma patients, optic nerve injuries, or
even spinal cord injuries. At the site of a lesion, LPA is present at micromolar levels to
help blood clotting (Aoki et al., 2002). If the lesion causes damage to a nerve, then there
needs to be a mechanism for that nerve to regenerate and make proper synaptic
connections again. It has been established that LPA-induced growth cone collapse is at
the nanomolar range (Birgbauer and Chun, 2010). Consequently, if LPA is responsible
for mediating axon guidance then the levels of LPA at a lesion site are too great for a
regenerating nerve to overcome since the inhibitory effects shown in in vitro studies is
potent. Additionally, future studies will be necessary to determine whether LPA has the
same physiological responses transitioning from developmental stages to adult. By
identifying the receptor responsible for this collapse, there is hope that by silencing LPA4
at the lesion site would aid nerve regeneration.
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